Physician profile
Jennifer Zaitz
NPI 1205031911
$538.15
in general payments reported to CMS, 2019-2025
13 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $13.90 · 2021: $48.09 · 2023: $104 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $151.41 | 2019 | |
| Tandem Diabetes Care, INC. | $71.10 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $53.21 | 2023-2025 | Minimed 780g |
| Novo Nordisk INC | $48.85 | 2019-2021 | |
| Amgen INC. | $35.04 | 2023-2025 | Tepezza, Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $33.56 | 2021 | |
| Sequel Med Tech, LLC | $33.48 | 2025 | Twiist |
| Insulet Corporation | $26.66 | 2025 | Omnipod |
| Amryt Pharma Holdings LTD | $24.15 | 2023 | Myalept |
| Valeritas, INC. | $17.59 | 2019 | |
| Ascendis Pharma Endocrinology INC | $16.01 | 2025 | Yorvipath |
| Ascensia Diabetes Care US INC. | $13.90 | 2019 | |
| Abbott Laboratories | $13.19 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Zaitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.